Skip to content

Investigating red light therapy for hypersensitive teeth during dental cleans

A study comparing the effectiveness of polychromatic light-emitting diode therapy for managing hypersensitive teeth during supragingival debridements in adults.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624001265561
Enrollment
60
Registered
2024-10-16
Start date
2026-04-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Fear of dental pain can produce anxiety and contribute to dental phobia. Recently, alternative methods for producing effective anaesthesia that reduce the pain experienced during dental procedures have been investigated. One such method is Photobiomodulation (PBM) which uses light to transiently block nerve transmission of pain. Clinical trials have shown that some lasers can generate analgesia using PBM. Therefore, the purpose of this study is to investigate whether a polychromatic light emitting diode (LED) device (Nuralyte®, Dentroid Canberra, Australia) can produce pulpal analgesia for hypersensitive teeth during supragingival debridements. It is hypothesised that the multiwavelength LED device (Nuralyte®, Dentroid Canberra, Australia) will be more effective when comparing the active light source to sham irradiation (single blinding for the participants). This study is being completed as part of Dr Jessica Zachar's Doctor of Philosophy (PhD) program at The University of Queensland.

Interventions

Objective: Compare the efficacy of pulpal analgesia following photobiomodulation (PBM) with a multiwavelength LED device (Nuralyte®, Dentroid Canberra, Australia) for hypersensitive teeth during supragingival debridements. Intervention: Participant blinded treatment for hypersensitive teeth during a supragingival debridement using either sham irradiation or actual light exposure with the Nuralyte® (Dentroid Canberra, Australia) - Light-emitting diode (LED) device. The device used in this s

Objective: Compare the efficacy of pulpal analgesia following photobiomodulation (PBM) with a multiwavelength LED device (Nuralyte®, Dentroid Canberra, Australia) for hypersensitive teeth during supragingival debridements. Intervention: Participant blinded treatment for hypersensitive teeth during a supragingival debridement using either sham irradiation or actual light exposure with the Nuralyte® (Dentroid Canberra, Australia) - Light-emitting diode (LED) device. The device used in this study is a polychromatic light-emitting diode (LED) device (Nuralyte®, Dentroid Canberra, Australia). It emits wavelengths of light from 700-1100nm with a spot size of 7mm and a measured power output of 113mW. The standard exposure time is 60 sec which will result in application of 6.77J of energy to the site with an energy density of 17.6 J/cm2. Who will deliver the intervention This trial will be undertaken by a registered general dentist or dental specialist. The intervention will administered in a clinical setting utilising appropriate personal protective equipment and following manufacturer instructions. Location where intervention will occur The study will occur at private practice dental clinics in Queensland, Australia (multi-centre study). Participant selection Adult dental patients (aged 18 years and above) who require a supragingival debridement as part of routine dental treatment will be invited to participate in the study. The registered dental practitioner or registered dental specialist will screen the patient and those who adhere to the inclusion criteria will be invited to participate. Mode of delivery/number of times delivered Each participant will be randomly assigned to receive either a sham exposure or the Nuralyte® device if a hypersensitive tooth is detected during supragingival debridement. If multiple sensitive teeth are detected and the participant is initially assigned to the sham exposure, only the first tooth will receive the sham treatment, while subsequent teeth will receive the active light treatment to ensure participants are not disadvantaged. If the Nuralyte device is to be used it will be applied to the tooth as a once off, for 60 seconds and adherence will be via direct observation by the dental practitioner. The operator needs to wait two minutes and can continue cleaning other teeth before returning to the tooth of interest with hypersensitivity for further cleaning. Afterwards, participants will be asked to report on the level of discomfort felt during the supraginginval debridement of that particular tooth. The registered general dental practitioner or dental specialist will also be required to record the following parameters at the time of the appointment on the provided data collection sheet: • Tooth of interest (FDI notation), patient age and gender • Pre-screening for history of hypersensitive teeth - Do you feel a short, sharp sensation in your teeth when you consume something cold, hot, sweet, or sour? and How often do you feel this short, sharp sensation in your teeth? • Brand of scaler used e.g EMS, Cavitron etc • Setting of the scaler % • Reported VAS pain scale for adult participants (1-10) at two time points Time point 1: When the hypersensitive tooth is detected during the supragingival clean Time point 2: After the hypersensitive tooth has received either Nuralyte or sham

Sponsors

The University of Queensland, School of Dentistry
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult dental patients (aged 18 years and above) who require a supragingival debridement as part of routine dental treatment will be invited to participate in the study. The registered dental practitioner or registered dental specialist will screen the patient and those who adhere to the inclusion criteria will be invited to participate. If a participant does not experience hypersensitive teeth during the debridement, they will be excluded from the study.

Exclusion criteria

Those who require sub-gingival debridement e.g ADA dental treatment code 222. Participants are also deemed ineligible if they have systemic conditions or are taking drugs that could influence pain perception. This includes oro-facial pain disorders, neurological/ cognitive/psychiatric conditions, obstructive sleep apnoea, and analgesic medications. Other exclusion criteria include those who lack the capacity for consent or those unable to comprehend pain.

Outcome results

None listed

Source: ANZCTR · Data processed: Aug 9, 2026